IBUPROFEN REQUIRED NDA FOR OTC MARKETING BECAUSE IT IS NEW, 200 MG DOSE, FDA TELLS CHATTEM IN MAY 18 REJECTION OF CITIZEN PETITION; POLICY DEFENDED

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet